Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced liver disease.

H J Zimmerman1

  • 1Armed Forces Institute of Pathology, Washington, DC, USA.

Clinics in Liver Disease
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Drug-induced liver disease is a significant cause of abnormal liver enzymes and acute liver failure in adults, particularly those over 50. It presents in various forms and can mimic other liver conditions, necessitating consideration of all ingested substances.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Encephalomyeloradiculitis (Guillain-Barré syndrome) as a complication of infectious hepatitis.

Annals of internal medicine·2010
Same author

Infectious hepatitis; clinical and laboratory features of 295 cases.

The American journal of the medical sciences·2010
Same author

Drug- and chemical-induced cholestasis.

Clinics in liver disease·2001
Same author

Management of drug-induced liver disease.

Current gastroenterology reports·2001
Same author

Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children.

The Journal of pediatrics·1998
Same author

Hepatitis associated with varicella infection in an immunocompetent adult.

Journal of clinical gastroenterology·1996
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Drug-induced liver disease (DILD) is a major cause of liver enzyme elevation in adults, ranging from 10% to 50%.
  • DILD accounts for approximately 25% of fulminant hepatic failure cases.
  • It is a critical consideration in patients over 50 years old.

Purpose of the Study:

  • To highlight the prevalence and diverse clinical presentations of drug-induced liver disease.
  • To emphasize the importance of considering all ingested agents, including herbal and traditional remedies, in diagnosing liver injury.
  • To discuss the varied patterns of liver injury and potential mimicry of other hepatic disorders.

Main Methods:

  • Review of clinical presentations and etiological factors of drug-induced liver injury.

Related Experiment Videos

  • Analysis of the spectrum of liver damage, including cytotoxic, cholestatic, and mixed patterns.
  • Case-based considerations of differential diagnoses for abnormal hepatic biochemistry.
  • Main Results:

    • Liver injury patterns can be cytotoxic, cholestatic, or mixed.
    • DILD can present with systemic manifestations and mimic autoimmune hepatitis, cirrhosis, or veno-occlusive disorders.
    • A wide range of systemic drugs and herbal/traditional agents can cause liver injury.

    Conclusions:

    • Drug-induced liver disease is a common and complex condition with diverse presentations.
    • Thorough patient history, including the use of herbal and traditional agents, is crucial for diagnosis.
    • Recognizing DILD is essential to differentiate it from other liver diseases and ensure appropriate management.